Drug
Ivermectin 1
Ivermectin 1: highest development phase Post-Market, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ivermectin 1% cream NCT03075891 | Post-Market | Rosacea |
Latest
No recent events.
Follow Ivermectin 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.